This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis
{ "resourceType": "EvidenceVariable", "id": "example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n\t\t <p>\n\t\t\tStroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis\n\t\t </p>\n\t\t</div>" }, "name": "Stroke Thrombolysis Trialists’ 2014-2016 IPD-MA Cohort", "title": "Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis", "status": "draft", "relatedArtifact": [ { "type": "citation", "label": "Emberson 2014", "display": "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.", "citation": "Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063", "document": { "url": "https://doi.org/10.1016/S0140-6736(14)60584-5" } }, { "type": "citation", "label": "Lees 2016", "display": "Figure 2 Lees 2016", "citation": "Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856", "document": { "url": "https://doi.org/10.1161/STROKEAHA.116.013644" } } ], "actual": true, "characteristic": [ { "description": "Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis", "definitionByCombination": { "code": "any-of", "characteristic": [ { "definitionReference": { "reference": "Group/ECASSIII-Trial-Cohort", "type": "Group", "display": "ECASS III Trial Cohort" } }, { "definitionReference": { "reference": "Group/IST3-Trial-Cohort", "type": "Group", "display": "IST3 Trial Cohort" } }, { "definitionReference": { "reference": "Group/ECASS-Trial-Cohort", "type": "Group", "display": "ECASS Trial Cohort" } }, { "definitionReference": { "reference": "Group/ECASSII-Trial-Cohort", "type": "Group", "display": "ECASSII Trial Cohort" } }, { "definitionReference": { "reference": "Group/EPITHET-Trial-Cohort", "type": "Group", "display": "EPITHET Trial Cohort" } }, { "definitionReference": { "reference": "Group/ATLANTIS-Trial-Cohort", "type": "Group", "display": "ATLANTIS Trial Cohort" } }, { "definitionReference": { "reference": "Group/NINDS-Trial-Cohort", "type": "Group", "display": "NINDS Trial Cohort" } } ] } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.